621670453	621670453	CD	B-NP	O
|	|	NN	I-NP	O
BAH	BAH	NN	I-NP	O
|	|	NN	I-NP	O
03477560	03477560	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4901294	4901294	CD	B-NP	O
|	|	CC	I-NP	O
8/1/2006	8/1/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hematoma	hematoma	NN	I-NP	O
vs	vs	IN	B-PP	O
mass	mass	NN	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
iliac	iliac	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/11/2006	8/11/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/28/2006	5/28/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
THENHAUS	THENHAUS	NN	B-NP	O
,	,	,	O	O
RORY	RORY	NN	B-NP	O
C	C	NN	I-NP	O
665-24-62-4	665-24-62-4	CD	I-NP	O
Mong	Mong	NNP	I-NP	O
A	A	NNP	I-NP	O
Procouport	Procouport	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/24/06	4/24/06	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
IMAIZUMI	IMAIZUMI	NNP	B-NP	O
,	,	,	O	O
NORMAND	NORMAND	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/26/06	9/26/06	CD	B-NP	O
by	by	IN	B-PP	O
STAVE	STAVE	NN	B-NP	B-protein
,	,	,	O	O
RICHIE	RICHIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
435098135	435098135	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	B-DNA
's	's	POS	B-NP	I-DNA
home	home	NN	I-NP	I-DNA
med	me	VBD	B-VP	I-DNA
ALBUTEROL	ALBUTEROL	NN	B-NP	I-DNA
INHALER	INHALER	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
PUFF	PUFF	NN	I-NP	I-DNA
INH	INH	NN	I-NP	I-DNA
QID	QID	NN	I-NP	I-DNA
COLACE	COLACE	NN	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
DOCUSATE	DOCUSATE	NNP	I-NP	I-DNA
SODIUM	SODIUM	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
DOXYCYCLINE	DOXYCYCLINE	NNP	I-NP	I-DNA
HYCLATE	HYCLATE	NNP	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
14	14	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
complete	complete	JJ	B-ADJP	O
on	on	IN	B-PP	O
4/12	4/12	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Take	Take	VB	B-VP	O
1	1	CD	B-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MAGNESIUM	MAGNESIUM	NNP	B-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
&	&	CC	I-NP	O
DOXYCYCLINE	DOXYCYCLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MAGNESIUM	MAGNESIUM	NNP	B-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
&	&	CC	I-NP	O
DOXYCYCLINE	DOXYCYCLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-ADJP	O
already	already	RB	B-ADVP	O
on	on	IN	B-PP	O
med	me	VBN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/26/06	9/26/06	CD	B-NP	O
by	by	IN	B-PP	O
ZAKAR	ZAKAR	NNP	B-NP	B-protein
,	,	,	O	O
NICKOLAS	NICKOLAS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MAGNESIUM	MAGNESIUM	NNP	B-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
&	&	CC	I-NP	O
DOXYCYCLINE	DOXYCYCLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MAGNESIUM	MAGNESIUM	NNP	B-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
&	&	CC	I-NP	O
DOXYCYCLINE	DOXYCYCLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
requires	require	VBZ	B-VP	O
ADVAIR	ADVAIR	NN	B-NP	O
DISKUS	DISKUS	NN	I-NP	O
500/50	500/50	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
NEB	NEB	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
MONOPRIL	MONOPRIL	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOSINOPRIL	FOSINOPRIL	NN	I-NP	I-protein
SODIUM	SODIUM	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/15/06	6/15/06	CD	B-NP	O
by	by	IN	B-PP	O
TOWNZEN	TOWNZEN	NN	B-NP	O
,	,	,	O	O
CARMELO	CARMELO	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
198982935	198982935	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FOSINOPRIL	FOSINOPRIL	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FOSINOPRIL	FOSINOPRIL	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
requires	require	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/15/06	6/15/06	CD	B-NP	O
by	by	IN	B-PP	O
MORGIA	MORGIA	NN	B-NP	O
,	,	,	O	O
ODIS	ODIS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CITRATE	CITRATE	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
140591477	140591477	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FOSINOPRIL	FOSINOPRIL	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CITRATE	CITRATE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FOSINOPRIL	FOSINOPRIL	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CITRATE	CITRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
requires	require	VBZ	B-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	B-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NNP	I-NP	I-protein
NEB	NEB	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
30	30	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Instructions	Instruction	NNS	B-NP	O
:	:	:	O	O
start	start	VB	B-VP	O
on	on	IN	B-PP	O
2/14	2/14	CD	B-NP	B-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
20	20	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/26/06	9/26/06	CD	B-NP	O
by	by	IN	B-PP	O
DRUCKER	DRUCKER	NN	B-NP	O
,	,	,	O	O
MOHAMMAD	MOHAMMAD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
435098135	435098135	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
med	me	VBD	B-VP	O
SPIRIVA	SPIRIVA	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
TIOTROPIUM	TIOTROPIUM	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
18	18	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
NEB	NEB	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	B-protein
1-2	1-2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
BACITRACIN	BACITRACIN	NN	B-NP	O
,	,	,	O	O
BACITRACIN/NEOMYCIN/POLYMYXIN	BACITRACIN/NEOMYCIN/POLYMYXIN	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
leg/groin	leg/groin	NN	I-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hematoma	hematoma	NN	I-NP	O
vs	vs	IN	B-PP	O
mass	mass	NN	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
iliac	iliac	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
COPD	COPD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
smoking	smoking	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
smoking	smoking	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pe	pe	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteopenia	osteopenia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteopenia	osteopenia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
crf	crf	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	B-DNA
renal	renal	JJ	I-NP	I-DNA
dysfunction	dysfunction	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
adrenal	adrenal	JJ	I-NP	I-DNA
mass	mass	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
adrenal	adrenal	JJ	I-NP	I-DNA
mass	mass	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
l	l	NN	I-NP	I-DNA
inguinal	inguinal	JJ	I-NP	I-DNA
hernia	hernia	NN	I-NP	I-DNA
-LRB-	-LRB-	HYPH	B-NP	I-DNA
inguinal	inguinal	JJ	I-NP	I-DNA
hernia	hernia	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
s/p	s/p	NN	I-NP	I-DNA
appy	appy	JJ	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
S/P	S/P	NN	I-NP	I-DNA
appendectomy	appendectomy	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
baseline	baseline	NN	I-NP	I-DNA
Cr	Cr	NN	I-NP	I-DNA
1.3-1	1.3-1	CD	I-NP	I-DNA
.5	.5	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	B-NP	O
18	18	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
left	left	JJ	B-NP	O
groin/leg	groin/leg	NN	I-NP	O
pain	pain	NN	I-NP	O
*****************	*****************	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
67	67	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
h/o	h/o	NN	I-NP	O
COPD	COPD	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
L	L	NN	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
5/17	5/17	CD	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
PE	PE	NN	I-NP	O
2/2	2/2	CD	I-NP	O
apical	apical	JJ	B-ADJP	O
thrombwith	thrombwith	IN	B-PP	O
10/25	10/25	CD	B-NP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Presents	Present	NNS	B-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
left	leave	VBD	B-VP	O
leg/groin	leg/groin	NN	B-NP	O
opain	opain	NN	I-NP	O
,	,	,	O	O
hurts	hurt	VBZ	B-VP	O
only	only	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
walking	walk	VBG	B-VP	O
on	on	IN	B-PP	O
it	it	PRP	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
Fevers/chills	Fevers/chill	NNS	I-NP	O
,	,	,	O	O
nausea/vomiting/diarrhea	nausea/vomiting/diarrhea	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
bac	bac	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
never	never	RB	B-ADVP	O
had	have	VBD	B-VP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
befoer	befoer	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
labs	lab	NNS	B-NP	O
sent	send	VBN	B-VP	O
,	,	,	O	O
attempted	attempt	VBN	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
spine	spine	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
then	then	RB	B-ADVP	O
got	get	VBD	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
PO	PO	NNP	B-NP	O
Ativan	Ativan	NNP	I-NP	O
to	to	TO	B-PP	O
,	,	,	O	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
and	and	CC	O	O
repeat	repeat	NN	B-NP	O
MRI	MRI	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
got	get	VBD	B-VP	O
Mucomyst	Mucomyst	NN	B-NP	O
for	for	IN	B-PP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
contrast	contrast	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
:	:	:	O	O
98.3	98.3	CD	B-NP	O
73	73	CD	I-NP	O
16126/64	16126/64	CD	I-NP	O
96	96	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4L	4L	NN	B-NP	O
NC	NC	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
Poor	Poor	NN	B-NP	O
air	air	NN	I-NP	O
movements	movement	NNS	I-NP	O
with	with	IN	B-PP	O
short	short	JJ	B-NP	O
breaths	breath	NNS	I-NP	O
-	-	HYPH	B-NP	O
little	little	JJ	I-NP	O
wheezing	wheezing	NN	I-NP	O
but	but	CC	O	O
lungs	lung	NNS	B-NP	O
sound	sound	VBP	B-VP	O
tight	tight	JJ	B-ADJP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Tachy	Tachy	NNP	B-NP	O
,	,	,	O	O
s1/s2	s1/s2	CD	B-NP	O
no	no	DT	B-NP	O
MRG	MRG	NN	I-NP	B-protein
.	.	.	O	O

Ext	Ext	NN	B-NP	O
:	:	:	O	O
Minimal	Minimal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Tenderness	Tenderness	NN	B-NP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
medial	medial	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
active	active	JJ	B-NP	O
and	and	CC	I-NP	O
passive	passive	JJ	I-NP	O
movement	movement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
overlying	overlie	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

**************	**************	SYM	O	B-protein
Labs	Lab	NNS	B-NP	I-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	O
of	of	IN	B-PP	O
165	165	CD	B-NP	O
139/4	139/4	CD	I-NP	O
.3	.3	NN	I-NP	O
/	/	SYM	B-NP	O
99/33/54	99/33/54	CD	B-NP	O
/	/	SYM	I-NP	O
1.4	1.4	CD	I-NP	O
CBC	CBC	NNP	I-NP	O
:	:	:	O	O
20.2	20.2	CD	B-NP	O
>	>	SYM	I-NP	O
41.3	41.3	CD	I-NP	O
<	<	SYM	I-NP	O
283	283	CD	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2.6	2.6	CD	B-NP	O
**************	**************	SYM	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
MRI	MRI	NN	B-NP	O
,	,	,	O	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
show	show	VBP	B-VP	O
density	density	NN	B-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
pelvis	pelvis	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-NP	O
consistent	consistent	JJ	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hematoma	hematoma	NN	I-NP	O
************	************	SYM	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Neuro	Neuro	NNP	I-NP	O
:	:	:	O	O
Weakness/pain	Weakness/pain	NNP	B-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
hip	hip	NN	I-NP	O
flexion	flexion	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
side	side	NN	I-NP	O
only	only	RB	B-ADVP	O
decr	decr	VBP	B-VP	O
sensation	sensation	NN	B-NP	O
in	in	IN	B-PP	O
medial	medial	JJ	B-NP	O
L2	L2	NN	I-NP	O
distribution	distribution	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
MRI	MRI	NN	B-NP	O
and	and	CC	I-NP	O
spine	spine	NN	I-NP	O
CT	CT	NN	I-NP	O
showing	show	VBG	B-VP	O
density	density	NN	B-NP	O
most	most	RBS	I-NP	O
c/w	c/w	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ID	ID	NN	I-NP	B-protein
-	-	HYPH	O	O
His	His	PRP$	B-NP	B-protein
elevated	elevated	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
possible	possible	JJ	B-NP	O
infectious	infectious	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
eg	eg	NN	B-NP	O
.	.	.	O	O

epidural	epidural	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
versus	versus	IN	B-PP	O
septic	septic	JJ	B-NP	O
joint	joint	JJ	I-NP	O
vs.	vs.	IN	B-PP	O
subq	subq	NN	B-NP	O
abcess	abcess	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
I	I	PRP	B-NP	O
-RRB-	-RRB-	VBP	B-VP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
P	P	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Echo	Echo	NNP	B-NP	O
1/14	1/14	CD	I-NP	O
-	-	HYPH	O	O
Appears	Appear	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

Will	Will	MD	O	O
continue	continue	VBP	B-VP	O
Monopril	Monopril	NNP	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

CV	CV	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
R	R	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Sinus	Sinus	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
On	On	NNP	B-NP	O
Home	Home	NNP	I-NP	O
O2	O2	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4L	4L	NN	B-NP	B-protein
.	.	.	O	O

Likely	Likely	RB	B-NP	O
chronic	chronic	JJ	I-NP	O
CO2	CO2	NN	I-NP	O
retainer	retainer	NN	I-NP	O
.	.	.	O	O

Titrating	Titrate	VBG	B-VP	O
O2	O2	NN	B-NP	O
for	for	IN	B-PP	O
sats	sat	NNS	B-NP	O
92-93	92-93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Made	Make	VBN	B-VP	O
his	his	PRP$	B-NP	O
nebs	neb	NNS	I-NP	O
standing	stand	VBG	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Complete	Complete	JJ	B-NP	O
Prednisone	Prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
and	and	CC	I-NP	O
doxycycline	doxycycline	NN	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
FEN	FEN	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Repleted	Replete	VBN	I-NP	O
K	K	NN	I-NP	O
and	and	CC	I-NP	O
Mag	Mag	NN	I-NP	B-protein
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

House	House	NNP	B-NP	O
diet.w	diet.w	NN	I-NP	O
/	/	SYM	B-NP	O
low	low	JJ	I-NP	O
sodium	sodium	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Renal	Renal	JJ	I-NP	O
-	-	HYPH	I-NP	O
Creatinine	Creatinine	NN	I-NP	O
sl	sl	NN	I-NP	O
.	.	.	O	O

elevated	elevate	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Appeared	Appear	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
prerenal	prerenal	JJ	I-ADJP	O
,	,	,	O	O
give	give	VBP	B-VP	O
IVF	IVF	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
?	?	.	O	O

history	history	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

Hgb	Hgb	NN	B-NP	B-protein
A1C	A1C	NN	I-NP	O
pending	pende	VBG	B-VP	O
,	,	,	O	O
fingerstick	fingerstick	VB	B-VP	O
QAC	QAC	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
RISS	RISS	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Heme	Heme	NN	I-NP	B-protein
-	-	HYPH	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Imaging	Imaging	NN	B-NP	O
via	via	IN	B-PP	O
CT	CT	NN	B-NP	O
and	and	CC	I-NP	O
MRI	MRI	NN	I-NP	B-protein
suggests	suggest	VBZ	B-VP	O
likely	likely	RB	B-NP	O
hematoma	hematoma	NN	I-NP	O
,	,	,	O	O
holding	hold	VBG	B-VP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
can	can	MD	B-VP	O
reassess	reassess	VB	I-VP	O
whether	whether	IN	B-SBAR	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
.	.	.	O	O

Suggest	Sugg	JJS	B-NP	O
repeat	repeat	NN	I-NP	O
CT	CT	NN	I-NP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
clot	clot	NN	B-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
:	:	:	O	O
DNI	DNI	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
DNR	DNR	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
get	get	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
CT	CT	NN	B-NP	B-protein
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
pelvic	pelvic	JJ	B-NP	B-protein
hematoma	hematoma	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

coumadin	coumadin	NN	B-NP	O
held	hold	VBD	B-VP	O
,	,	,	O	O
consider	consider	VB	B-VP	O
restarting	restart	VBG	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
recommendations	recommendation	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
.	.	.	O	O

complete	complete	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
doxycycline	doxycycline	NN	B-NP	O
,	,	,	O	O
complete	complete	JJ	B-ADVP	O
4/12	4/12	CD	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

complete	complete	JJ	B-NP	O
slow	slow	JJ	I-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-PP	O
written	write	VBN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
decr	decr	NN	I-NP	O
dose	dose	NN	I-NP	O
q3days	q3day	NNS	I-NP	O
-RRB-	-RRB-	SYM	O	O
5	5	CD	B-NP	O
.	.	.	O	O

Hb	Hb	NN	B-NP	B-protein
A1C	A1C	NN	I-NP	O
6.4	6.4	CD	I-NP	O
on	on	IN	B-PP	O
5/14	5/14	CD	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VENTRELLA	VENTRELLA	NNP	B-NP	O
,	,	,	O	O
ARMANDO	ARMANDO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VW59	VW59	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/24/06	4/24/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
:	:	SYM	I-NP	O
13	13	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

